Akero Therapeutics CEO and Key Executive Team

• Jonathan Young

  Chief Operating Officer & Co-Founder
• Mark Iwicki

  Chairman
• William White

  Chief Financial Officer and Head of Corporate Development
• Andrew Cheng

  President, Chief Executive Officer & Director
• Catriona Yale

  Chief Development Officer
• Seth L. Harrison

  Independent Board Member
• Arin Bose

  Vice President for Drug Substance Process Development
• Graham Walmsley

  Independent Board Member
• Jane Pritchett Henderson

  Independent Board Member
• John Schembri

  Vice President, Finance and Controller
• Reshma Shringarpure

  Vice President, Clinical Research and Medical Affairs
• Tom Heyman

  Independent Board Member
• Judy Chou

  Independent Board Member
• Tim Rolph

  Chief Scientific Officer & Co-Founder
• Yuan Xu

  Independent Board Member
• Dominick Villani

  Vice President, Quality
• Brittany de Temple

  Vice President of Development Operations
• Libette Luce

  Vice President of Regulatory Affairs
• Patrick Lamy

  Senior Vice President of Commercial Strategy

Source: akerotx.com, akerotx.com